|
ZFP64 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.020070E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.187200E-04 |
| Normal-vs-Stage2 |
1.842370E-01 |
| Normal-vs-Stage3 |
2.570200E-04 |
| Normal-vs-Stage4 |
1.388860E-04 |
| Stage1-vs-Stage2 |
8.037800E-02 |
| Stage1-vs-Stage3 |
4.827000E-01 |
| Stage1-vs-Stage4 |
2.173000E-01 |
| Stage2-vs-Stage3 |
5.104000E-02 |
| Stage2-vs-Stage4 |
2.453700E-02 |
| Stage3-vs-Stage4 |
5.392800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.48750000000553E-05 |
| Normal-vs-AfricanAmerican |
5.481800E-02 |
| Normal-vs-Asian |
4.138000E-02 |
| Caucasian-vs-AfricanAmerican |
4.496400E-01 |
| Caucasian-vs-Asian |
2.250200E-01 |
| AfricanAmerican-vs-Asian |
8.815800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.985990E-04 |
| Normal-vs-Female |
2.434400E-04 |
| Male-vs-Female |
4.491400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.233450E-04 |
| Normal-vs-Age(41-60Yrs) |
8.841800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.841810E-03 |
| Normal-vs-Age(81-100Yrs) |
2.575800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.472000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.759600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.732600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.807600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.128200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.410200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.947580E-01 |
| Classical-VS-Follicular |
9.805800E-01 |
| Classical-VS-Other |
7.007000E-01 |
| Classical-VS-Normal |
2.385700E-04 |
| Tall-VS-Follicular |
2.590400E-01 |
| Tall-VS-Other |
9.838600E-01 |
| Tall-VS-Normal |
8.778400E-04 |
| Follicular-VS-Other |
6.400800E-01 |
| Follicular-VS-Normal |
1.034310E-02 |
| Other-VS-Normal |
8.110100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.144400E-03 |
| Normal-vs-N1 |
4.89800000003093E-06 |
| N0-vs-N1 |
5.456700E-03 |
|
|
